ReiThera, Exothera collaborate to develop large scale low cost per dose manufacturing process to deliver novel vaccines to low and middle-income countries

ReiThera Srl, a biotech company, and Exothera, a full-service CDMO, announced that they have entered into a collaboration agreement to develop a large-scale, low cost per dose manufacturing process for the production of ReiThera